Cariou Alain, Payen Jean-François, Asehnoune Karim, Audibert Gerard, Botte Astrid, Brissaud Olivier, Debaty Guillaume, Deltour Sandrine, Deye Nicolas, Engrand Nicolas, Francony Gilles, Legriel Stéphane, Levy Bruno, Meyer Philippe, Orban Jean-Christophe, Renolleau Sylvain, Vigue Bernard, De Saint Blanquat Laure, Mathien Cyrille, Velly Lionel
Medical Intensive Care Unit, Cochin University Hospital (APHP) & Paris Descartes University, 27 rue du Faubourg Saint-Jacques, 75014, Paris, France.
Pôle Anesthésie-Réanimation, Hôpital Michallon, CHU Grenoble Alpes, 38000, Grenoble, France.
Ann Intensive Care. 2017 Dec;7(1):70. doi: 10.1186/s13613-017-0294-1. Epub 2017 Jun 19.
Over the recent period, the use of induced hypothermia has gained an increasing interest for critically ill patients, in particular in brain-injured patients. The term "targeted temperature management" (TTM) has now emerged as the most appropriate when referring to interventions used to reach and maintain a specific level temperature for each individual. TTM may be used to prevent fever, to maintain normothermia, or to lower core temperature. This treatment is widely used in intensive care units, mostly as a primary neuroprotective method. Indications are, however, associated with variable levels of evidence based on inhomogeneous or even contradictory literature. Our aim was to conduct a systematic analysis of the published data in order to provide guidelines. We present herein recommendations for the use of TTM in adult and paediatric critically ill patients developed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) method. These guidelines were conducted by a group of experts from the French Intensive Care Society (Société de Réanimation de Langue Française [SRLF]) and the French Society of Anesthesia and Intensive Care Medicine (Société Francaise d'Anesthésie Réanimation [SFAR]) with the participation of the French Emergency Medicine Association (Société Française de Médecine d'Urgence [SFMU]), the French Group for Pediatric Intensive Care and Emergencies (Groupe Francophone de Réanimation et Urgences Pédiatriques [GFRUP]), the French National Association of Neuro-Anesthesiology and Critical Care (Association Nationale de Neuro-Anesthésie Réanimation Française [ANARLF]), and the French Neurovascular Society (Société Française Neurovasculaire [SFNV]). Fifteen experts and two coordinators agreed to consider questions concerning TTM and its practical implementation in five clinical situations: cardiac arrest, traumatic brain injury, stroke, other brain injuries, and shock. This resulted in 30 recommendations: 3 recommendations were strong (Grade 1), 13 were weak (Grade 2), and 14 were experts' opinions. After two rounds of rating and various amendments, a strong agreement from voting participants was obtained for all 30 (100%) recommendations, which are exposed in the present article.
近年来,亚低温治疗在重症患者中越来越受到关注,尤其是在脑损伤患者中。现在,“目标温度管理”(TTM)一词在提及用于为每个个体达到并维持特定体温水平的干预措施时,已成为最合适的术语。TTM可用于预防发热、维持正常体温或降低核心体温。这种治疗方法在重症监护病房中广泛应用,主要作为一种主要的神经保护方法。然而,基于不均匀甚至相互矛盾的文献,其适应症的证据水平各不相同。我们的目的是对已发表的数据进行系统分析,以提供指导方针。在此,我们提出使用GRADE(推荐分级评估、制定和评价)方法制定的针对成人和儿童重症患者使用TTM的建议。这些指南由法国重症医学会(Société de Réanimation de Langue Française [SRLF])和法国麻醉与重症医学学会(Société Francaise d'Anesthésie Réanimation [SFAR])的一组专家制定,法国急诊医学协会(Société Française de Médecine d'Urgence [SFMU])、法国儿科重症监护与急诊小组(Groupe Francophone de Réanimation et Urgences Pédiatriques [GFRUP])、法国国家神经麻醉与重症监护协会(Association Nationale de Neuro-Anesthésie Réanimation Française [ANARLF])以及法国神经血管学会(Société Française Neurovasculaire [SFNV])参与其中。15名专家和2名协调员同意考虑关于TTM及其在心脏骤停、创伤性脑损伤、中风、其他脑损伤和休克这五种临床情况中的实际应用的问题。这产生了30条建议:3条为强烈推荐(1级),13条为弱推荐(2级),14条为专家意见。经过两轮评分和多次修改,投票参与者对所有30条(100%)建议达成了强烈共识,本文将予以公布。